Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
UNIVERSIDAD DE ZARAGOZA has 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This action is assigned to 1 distinct examiner and 1 distinct art unit. The university's current patent prosecution is concentrated in a single technical area and handled by a single examiner, reflecting a very specific technical focus for their current patenting efforts. This concentration allows for a streamlined interaction with the USPTO but concentrates the risk on a single matter.
BUNNER, BRIDGET E is the busiest examiner for this portfolio, managing 1 pending office action. This single action accounts for the entirety of the pending matters for the university. The involvement of only 1 distinct art unit and 1 distinct examiner suggests that the university is currently pursuing a narrow technical path. Practitioners should analyze the specific examination history of BUNNER, BRIDGET E to anticipate the likely challenges and requirements for this pending action.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 2 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BUNNER, BRIDGET E | 1 | 64.6% | +19.8% |
| WANG, CHANG YU | 1 | 33.4% | +53.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18005998 | INHIBITORS OF ALPHA-SYNUCLEIN AGGREGATION AND USES THEREOF | WANG, CHANG YU | 10d overdue |
| 18030974 | COMBINATIONS OF ANTI-INFLAMMATORY AGENTS FOR TREATING ACUTE ORGAN FAILURE, ARDS, ORGANS FOR TRANSPLANTATION OR DISEASES CAUSED BY AN AIRWAY-TARGETING VIRUS | BUNNER, BRIDGET E | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18005998 | INHIBITORS OF ALPHA-SYNUCLEIN AGGREGATION AND USES THEREOF | WANG, CHANG YU | 10d overdue |
| 18030974 | COMBINATIONS OF ANTI-INFLAMMATORY AGENTS FOR TREATING ACUTE ORGAN FAILURE, ARDS, ORGANS FOR TRANSPLANTATION OR DISEASES CAUSED BY AN AIRWAY-TARGETING VIRUS | BUNNER, BRIDGET E | — |
| Art Unit | Apps |
|---|---|
| 1647 | 1 |
| 1675 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18030974 | COMBINATIONS OF ANTI-INFLAMMATORY AGENTS FOR TREATING ACUTE ORGAN FAILURE, ARDS, ORGANS FOR TRANSPLANTATION OR DISEASES CAUSED BY AN AIRWAY-TARGETING VIRUS | BUNNER, BRIDGET E | 1647 | §102§112 | Non-Final OA | — | Pending | Apr 07, 2023 |
| 18005998 | INHIBITORS OF ALPHA-SYNUCLEIN AGGREGATION AND USES THEREOF | WANG, CHANG YU | 1675 | §102§103§112 | Final Rejection | 10d overdue | Pending | Jan 19, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialUNIVERSIDAD DE ZARAGOZA has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
Bridget E Bunner has the most, with 1 of UNIVERSIDAD DE ZARAGOZA's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
